The links on this page are provided to help you find additional information on web sites maintained by government and private organizations and for-profit companies. They are maintained solely for your convenience.
When you click to another site, please be aware that CHRISTUS Stehlin Foundation does not control and cannot guarantee the content, relevance, timeliness, or accuracy of the information contained there. Further, the inclusion of a link to a particular site is not intended to reflect its validity or importance, nor is it intended to constitute approval or endorsement of any views expressed or implied, or of products or services offered.
April 22, 2012
Combining a spirit of fun with a worthy philanthropic effort, Susan's Rally takes participants on an afternoon adventure in their automobiles and raises money for the fight against breast cancer!
“I think it has been too easy to overlook what a progressive physician Dr. John Stehlin was, and how pivotal he was for the humane treatment of individuals with cancer. He changed the cancer landscape forever, and his work continues with the research the CHRISTUS Stehlin Foundation is doing today.”
Dr. Peter de Ipolyi,
Surgical Oncologist
The cancer drug bexarotene quickly eliminates Alzheimer's disease-associated amyloid beta from the brain and reverses memory problems in mice, a new study finds. The results suggest that bexarotene could help the 5.4 million Americans with Alzheimer's disease.
An international research team has made a breakthrough that could change the way pediatric cancers are treated in the future. The researchers identified two genetic mutations responsible for up to 40 per cent of glioblastomas in children.